Albumin-to-creatinine ratio as non-invasive marker for prediction of non- bleeding esophageal varices. a cross-sectional observational study - Summary - MDSpire

Albumin-to-creatinine ratio as non-invasive marker for prediction of non- bleeding esophageal varices. a cross-sectional observational study

  • By

  • Nasser Mousa

  • Alaa Elmetwalli

  • Mostafa abdelsalam

  • Mohamed Wahba

  • Niveen El-wakeel

  • Marwa Mansour

  • Mohamed Selim

  • Muhammad Diasty

  • Eman Abdelkader

  • Adel El-Assmy

  • Mohammed Abdelaziz

  • Ali El-Assmy

  • Ahmed Alhawarey

  • July 10, 2026

  • 0 min

Share

Objective:

To evaluate the albumin to creatinine ratio as a useful non-invasive parameter for predicting non-bleeding esophageal varices in patients with liver cirrhosis.

Approach:
  • Statistical Analysis: Statistical analysis was performed using SPSS, including descriptive statistics, comparisons, and ROC curve analysis to evaluate the predictive value of ACR.
Key Findings:
  • The study included 260 patients with liver cirrhosis.
  • ACR was calculated from blood samples to assess its predictive value for non-bleeding esophageal varices.
  • Standardized diagnostic criteria were applied for cirrhosis and variceal classification.
Interpretation:

Limitations:
  • The study was limited to a specific population in Egypt, which may affect generalizability.
  • Potential loss of cases during follow-up was anticipated, necessitating a larger sample size.
Conclusion:

Original Source(s)

Albumin-to-creatinine ratio as non-invasive marker for prediction of non- bleeding esophageal varices. a cross-sectional observational study

  • by Nasser Mousa, Alaa Elmetwalli, Mostafa abdelsalam, Mohamed Wahba, Niveen El-wakeel, Marwa Mansour, Mohamed Selim, Muhammad Diasty, Eman Abdelkader, Adel El-Assmy, Mohammed Abdelaziz, Ali El-Assmy, Ahmed Alhawarey

  • July 10, 2026

Related Content

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review

Plasma gamma-glutamylglycine predicts the seroconversion of hepatitis B e antigen in patients with chronic hepatitis B

Targeting macrophages in liver fibrosis